Envestnet Asset Management
MBOT icon

Envestnet Asset Management’s Microbot Medical MBOT Stock Holding History

Envestnet Asset Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.5K Buy
47,426
+2,804
+6% +$5.72K ﹤0.01% 4764
2026
Q1 		$108K Buy
44,622
+8,959
+25% +$20K ﹤0.01% 4616
2025
Q4 		$71.3K Buy
35,663
+3,399
+11% +$8.05K ﹤0.01% 4395
2025
Q3 		$98.4K Buy
+32,264
New +$101K ﹤0.01% 4426
2025
Q2 		– Sell
-41,742
Closed -$63K – 4513
2025
Q1 		$63K Buy
+41,742
New +$73.8K ﹤0.01% 4285

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Envestnet Asset Management's MBOT Position: Q2 2026 in Review

Envestnet Asset Management increased its Microbot Medical (MBOT) stake by 6.3% in Q2 2026, buying an estimated $5.72K and bringing the position to 47,426 shares worth $92.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4764.

Envestnet Asset Management first reported a position in MBOT in Q1 2025 and has held it in 5 quarters since. The position peaked at $108K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Envestnet Asset Management held 47,426 shares of Microbot Medical worth $92.5K as of Q2 2026.
  • Envestnet Asset Management bought 2,804 Microbot Medical shares in Q2 2026, an estimated $5.72K.
  • Microbot Medical made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4764 holding.
  • Envestnet Asset Management first reported a position in Microbot Medical in Q1 2025 and has held it in 5 quarters since.
  • Envestnet Asset Management's Microbot Medical position peaked at $108K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.